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ABSTRACT
Objective: The aim of this study is to observe the activity of ethanol extract of Curanga fel-terrae leave in preventing the damaged of liver which is 
induced by high dose of paracetamol.
Methods: This research was conducted using Wistar rat divided into six groups. Group 1 was the normal group. Groups 2, 3, 4, 5, and 6 received 
carboxymethyl cellulose-Na 0.5% (negative control), C. fel-terrae ethanolic extract (CFEE) at the doses of 125, 250 and 500 mg/kg, catechin 2 mg/kg 
(positive control), respectively, during 7 days continued and followed by given paracetamol dose of 2.5 g/kg 8 hrs. After that, hepatoprotective activity 
was carried out toward parameter of aspartate aminotransferase (AST), alanine aminotransferase (ALT) as well as histopathology of the liver.
Results: The results showed that high dose paracetamol dose of 2.5g/kg bw can cause liver damaged which can be seen by the increasing of the level 
of AST and ALT compared to the normal group (p<0.05). The usage of three doses of CFEE for 7 days showed the prevention of the increasing of the 
level of AST and ALT compared to negative control group (p<0.05). Furthermore, the histopathology study revealed that the three doses of extract 
could protect the liver.
Conclusion: The CFEE at the doses of 125, 250 and 500 mg/kg bw which was given for 7 days can prevent the liver from the damage caused by a high 
dose of paracetamol.
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INTRODUCTION
The liver plays an important role in body metabolism activity, which 
is the main organ for detoxification. The liver can experience damage 
which caused by some toxic chemicals and drugs, therefore it could be 
a very serious problem [1]. Herbal drugs have been known to have a 
significant role in some diseases treatments. The research of effective 
hepatoprotective drug has been continued although some of the herbal 
drugs had been reported could accelerate the natural healing process 
of liver disease [2].
In this world, particularly Indonesia has the variety of plants 
which is a potential source in the finding of the new drug, 
especially as marker compound [3]. One group of the plant which 
has potential as the source of the new drug is Scrophulariaceae 
family. The pharmacological activity investigation to this family 
included antiviral [4-6], antimicrobials [7,8], antioxidant [7,9], 
analgesic [4,10], anti-inflammation [4,11,12], immunomodulator [11], 
antidepressant [13], diuretic [4,14], antidiabetic [4,15], antimalarial, 
anticancer, inotropic [4], hepatoprotective [16], antispasmodic, 
anticholinesterase, antiulcerogenic, antileishmanial [17], 
antidiarrheal [18], and antitumor [19].
Pugun tano (Curanga fel-terrae (Lour.) Merr.) is a plant from 
Scrophulariaceae family which grow in Asian regions such as China, 
India, Indonesia, Philippine, Malaysia, and Myanmar. In Indonesia, 
this plant is spread in Sumatera, Java, Kalimantan, and Maluku [20]. 
Some researchers showed that this plant contained glycoside [21,22], 
flavonoid [23], saponin [24], terpenoid [25], curangin, and bitter 
compound [26]. The pharmacological activity of this plant also has 
been studied such as anthelmintic [27], antidiabetic [28], anti-breast 
cancer [29-31], diuretic effect [32], cardioprotective effect [33], and 
antimuscarinic receptor [34]. In this study, the effect of ethanol extract 
of pugun tano was examined for the hepatoprotective activity since this 
plant in Scrophulariaceae family.
METHODS
Plant materials
Pugun tano (C. fel-terrae (Lour.) Merr.) plant was collected from Pancur 
Batu Subdistrict, Deli Serdang District, North Sumatera Province. 
Taxonomic identification was made from Biology Research Centre 
of Herbarium Bogoriense. A voucher specimen (No:1553/IPH.1.02/
if.8/IX/2013) has been deposited at the herbarium of the Botany 
Department.
Plant extraction
The leaves were washed and dried at 30-35°C, then ground until dried 
powder was obtained. The dried powder was percolated using 96% 
ethanol then the obtained crude extract was evaporated and kept at 4°C 
refrigerator.
Animals
The animals used in this study were male Wistar rats (150-200 g). The 
rats were bred in the colony in the Animal House of Faculty of Pharmacy 
(University of Sumatera Utara). They were fed a standard pellet diet 
and water ad libitum. Before their use in the experiment, rats were kept 
in standard environment condition. Ethical clearance was obtained 
from Animal Research Ethics Committee, University of Sumatera Utara 
(approved number: 100/KEPH-FMIPA/2014) before initiating the 
experiments.
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Hepatoprotective activity
The animals were divided into six groups, and each group consisted of 
five animals. The hepatoprotective activity of the extract was examined 
using a high dose of paracetamol (2.5 g/kg bw) as hepatotoxicity 
inducer. The tested extract was given for 7 days, and then paracetamol 
was given at day 8. The experiment groups were tabulated in Table 1.
Biochemistry measurement parameter
On the day 9 or 24 hrs after paracetamol had been given, blood and 
livers were taken from all animals. The obtained blood was centrifuged 
and serum was taken, then aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) measurements were conducted at 
Health Laboratorium Bureau, Medan.
Liver histopathology
Livers from the experiment animals were taken and immersed in 10% 
formalin buffer. The livers were processed using the routine histology 
procedure and made a section with 4-6 µm widths. The tissues were 
stained with hematoxylin-eosin and observed under a microscope.
Data analysis
The results were expressed as a mean value±standard error of mean. 
Analysis of variance was used to compare the results of experiments. 
The significance of the interactions between groups was determined 
using Tukey HSD post hoc test with the p<0.05 considered to be 
significant.
RESULTS AND DISCUSSION
Effect of C. fel-terrae ethanolic extract (CFEE) on ALT level
ALT is enzyme normally most distributed in the liver cell. In ALT 
measurement, liver positively damages if the number of this enzyme 
in plasma more than the normal level. The result of ALT level after 
treatments for each group can be seen in Table 2.
Based on Fig. 1, it showed that the negative control group (given 
carboxymethyl cellulose [CMC]-Na only for 7 days before high dose 
paracetamol) had a very significant increase of ALT level compared to 
the normal group. It showed that the given of high dose paracetamol 
caused liver damage. Liver damage leads to high level of serum markers 
in the blood, among these, AST, ALT represents 90% of total enzyme, 
and high level of ALT in the blood is a better index of liver damage [35]. 
The given of CFEE with doses of 125, 250 and 500 mg/kg BW did not 
show a significant increase of ALT level compared to normal group 
(p≥0.05) and significantly different with negative control (p<0.05). It 
showed that all the doses of CFEE could inhibit the liver damage.
Effect of CFEE on AST level
AST or aspartate aminotransferase is an enzyme normally found in 
liver and heart. AST is released into the blood stream if liver or heart 
experiences damage. Based on the experiment, the AST level for each 
group after treatment was shown in Table 3.
Based on Table 3 and Fig. 2, the tested animals are given CFEE with 
doses of 125, 250 and 500 mg/kg BW could inhibit the increase of AST 
level caused by high dose paracetamol induction. A very well inhibition 
was occurred and significantly difference with the negative control 
group (p<0.05). Although the extract treatment groups had shown 
similar AST level with the normal control group (p≥0.05), it could be 
said that the CFEE could protect the liver cells from the damage induced 
by high dose paracetamol. While the increase of CFEE dose from 125 
to 250 and 500 mg/kg did not show a significant effect. All doses had 
similar strength to protect the liver.
Table 1: Group of treatments
Group Treatment
I Animals were given standard food and 
water ad libitum without tested extract and 
paracetamol (normal control)
II Animals were given CMC-Na for 7 days and 
paracetamol on day 8 (negative control)
III Animals were given CFEE with a dose of 
125 mg/kg bw for 7 days and paracetamol on day 8
IV Animals were given CFEE with a dose of  
250 mg/kg bw for 7 days and paracetamol on day 8
V Animals were given CFEE with a dose of  
500 mg/kg bw for 7 days and paracetamol on day 8
VI Animals were given catechin with dose of  
2 mg/kg bw for 7 days and paracetamol on day 
8 (positive control/reference)
CFEE: Curanga fel-terrae ethanolic extract, CMC: Carboxymethyl cellulose
Table 2: ALT level after extract treatment and high dose 
paracetamol induction.
Group ALT level (U/L)
Normal 38.60±3.172a
Negative control (CMC-Na) 330.00±139.421
CFEE 125 mg/kg 71.00±9.778ab
CFEE 250 mg/kg 71.40±11.847ab
CFEE 500 mg/kg 46.20±9.107ab
Positive control (catechin 2 mg/kg) 47.00±11.305ab
aSignificant difference with negative control (p<0.05). bNot significant difference 
with normal group (p≥0.05). Data were presented as mean±standard error of 
mean (n=5). CFEE=Curanga fel-terrae ethanol extract, CMC: Carboxymethyl 
cellulose, ALT: Alanine aminotransferase
Fig. 1: Alanine aminotransferase level of the treatment groups 
after Curanga fel-terrae ethanolic extract (CFEE) and high dose 
paracetamol given. 1 - Negative control, 2 - CFEE of 125 mg/kg, 
3 - CFEE of 250 mg/kg, 4 - CFEE of 500 mg/kg, 5 - Catechin 
2 mg/kg, and 6 - Normal group
Fig. 2: Aspartate aminotransferase level of the treatment 
groups after Curanga fel-terrae ethanolic extract (CFEE) 
and high dose paracetamol were given. 1 - Negative control, 
2 - CFEE of 125 mg/kg bw, 3 - CFEE of 250 mg/kg bw, 4 - CFEE of 
500 mg/kg BW, 5 - Catechin 2 mg/kg bw, and 6 - Normal group
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In this study, rats were given with a high dose of paracetamol, 2.5 g/kg BW. 
Paracetamol was metabolized in the liver resulting radical metabolite 
which is called N-acetyl-p-benzoquinone imine (NAPQI). In normal 
condition, NAPQI will be rapidly detoxed by the glutathione from the 
liver. However, in the high dose of paracetamol, the liver will not be able 
to detox the excessive NAPQI. The radical metabolite will damage the 
liver. Antioxidant activity from various secondary metabolite in the plant 
like pugun tano is expected to stimulate the endogen antioxidant like 
glutathione. Glutathione with the assistance of glutathione-S-transferase 
enzyme could conjugate the reactive paracetamol metabolite, NAPQI, by 
bonding with the sulfhydryl group to form unradical compounds such as 
mercapturic acid and cysteine conjugate.
Beside the endogen antioxidant enhancement mechanism, the plant 
secondary metabolite could also protect the liver from various ways. One 
of the flavonoids from seed and fruit of Silybum marianum (Compositae) 
called silymarin had been known the mechanism in protecting the liver. 
Silymarin was reported could increase the hepatocyte proliferation 
in damage liver [36]. Furthermore, this compound could control the 
permeability and integrity of cell membrane, inhibited the leukotriene 
and reactive oxygen species entrapping, suppressed the nuclear factor-
κB activity, and several other mechanisms [37]. Therefore, pugun tano 
with the high content of the flavonoids is suggested to be able to protect 
the liver by the same mechanism like silymarin.
Apart from flavonoid, glycoside also had a role in protecting the liver. 
The mechanism was assumed by the conjugation of the first phase 
metabolite with the sugar molecule which will be easily eliminated 
from the body.
Effect of CFEE on liver organ
The macroscopical observation of liver organ showed the difference 
between the normal, negative control, positive control and CFEE with 
doses of 125, 250 and 500 mg/kg group included the color and texture 
of liver. The results were presented in Table 4 and Fig. 3.
Histopathology result for liver tissue
Histopathology observation was done on day 8 or 24 hrs after 
paracetamol had been given. The rats were neck dislocated then the 
livers were taken. This observation result was used to determine 
the level of liver cells damage caused by paracetamol and the 
hepatoprotective effect of the given extract (CFEE). Through this 
histopathology observation, it could be seen the tissue damage which 
could not be determined by macroscopical observation.
It can be seen in Table 5 that the normal, positive control and CFEE doses 
of 125, 250 and 500 mg/kg BW group showed no hepatocyte damage, 
while the negative control group showed the hydropic degeneration 
and necrotic. It showed that the given of 2 g/kg BW paracetamol could 
damage the liver through the NAPQI metabolite formation and the 
decrease of liver glutathione level, therefore the liver macromolecule 
cell bonding by NAPQI metabolite occurred whereby damage the liver 
cell. The results of liver histopathology could be seen in Fig. 4.
Normal group (P1) showed normal central vein. Central vein is a vein 
surrounded by compact endothelium cell and located at central lobule 
with circled hepatocyte to the central vein. In the hepatocyte, there is 
complete cytoplasm with circle nucleus. Along the hepatocyte, there is 
blood vessel as a place for blood to flow then will be collected by central 
vein. The negative control group (P2) showed an indication of liver 
structure damage which assigned by the congested central vein caused 
by the endothelium cell lysis, therefore the circle became incomplete 
and at the end became unclear. The damage to the central vein related to 
its function on the circulation, whereby the central vein received blood 
from the blood vessels. Therefore, the central vein will collect most of the 
toxic or non-toxic nutrients and metabolites. The more volume of blood 
collected by central vein will cause the toxic substances concentration 
Table 3: AST level after extract treatment and high dose 
paracetamol induction
Kelompok AST level (U/L)
Normal 77.40±6.875a
Negative control (CMC-Na) 271.80±41.470
CFEE 125 mg/kg 69.20±10.632ab
CFEE 250 mg/kg 132.00±32.862ab
CFEE 500 mg/kg 59.00±6.434ab
Positive control (catechin 2 mg/kg) 65.40±10.652ab
aSignificant difference with negative control (p<0.05). bNot significant difference 
with normal group (p≥0.05). Data were presented as mean±standard error of 
mean (n=5). CFEE=Curanga fel-terrae ethanol extract, CMC: Carboxymethyl 
cellulose, AST: Aspartate aminotransferase
Fig. 3: Macroscopic of rat liver organ. P1 - Normal rat liver, 
P2 - Negative control rat liver, P3 - Positive control rat liver, 
P4 - 125 mg/kg bw Curanga fel-terrae ethanolic extract (CFEE) rat 
liver, P5 - 250 mg/kg bw CFEE rat liver, P6 - 500 mg/kg bw CFEE 
rat liver 
Table 4: Macroscopically observation of liver tissue after 
treatment for each group
Treatment Macroscopic of liver
Color Texture
Normal Red Smooth
Negative control (CMC-Na) Pale red with black 
spot
Smooth
CFEE 125 mg/kg Pale red with 
brown-black spot
Smooth
CFEE 250 mg/kg Dark red with red 
spot
Smooth
CFEE 500 mg/kg Red Smooth
Positive control (catechin 2 mg/kg) Dark red Smooth
CFEE: Curanga fel-terrae ethanol extract, CMC: Carboxymethyl cellulose
Table 5: Histopathology result based on hepatocyte damage








P1: Normal, P2: Negative control, P3, P4, P5: Doses of 125, 250 and 
500 mg/kg bw CFEE, P6: Positive control. -: Normal, +: Damage, CFEE: Curanga 
fel-terrae ethanol extract
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higher then it will damage the central vein. In the hepatocyte cell, 
it was seen the liver cell also occurred necrotic which had shown by 
the small nuclei and black in color (pyknotic nuclei), lysis nuclei (car 
recsys), and destroy nuclei (karyolysis). The P2 group showed the 
hydropic degeneration cell. The cell inflamed and the vacuole became 
large. This phenomenon was aligned with the theory which stated that 
the hydropic degeneration was the first sign of cell damage because 
the cell membrane permeability disruption caused by the decrease of 
ATP number. The figure of liver histology of positive control group (P3), 
CFEE with doses of 125, 250 and 500 mg/kg bw (P4, P5, and P6) did not 
show a significant damage compared to the negative control group. The 
histological changes induced by paracetamol treatment as evidenced 
by the congested central vein and hepatic necrosis and its protection 
to normalcy by the treatment with the plant extract were indicative of 
the hepatoprotection of the extract [38]. It proved that the CFEE could 
protect the liver from damage and had hepatoprotective activity on rat 
liver induced by paracetamol.
CONCLUSION
This study concluded that pugun tano ethanolic extract had 
hepatoprotective activity with the parameter of ALT and AST level 
inhibition in rat liver induced by high dose paracetamol.
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